Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350977 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Violetta S Gogoleva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Mechanisms of Immunity, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Lymphotoxin-alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Lymphotoxin α and lymphotoxin β (LTs), TNF superfamily members, are expressed in either soluble (LTα 3 ) or membrane‐bound (LTα 1 β 2 or LTα 2 β 1 ) forms. In the pathological context, LT‐mediated signaling is known to exacerbate autoimmunity by perpetuating inflammation and promoting the formation of tertiary lymphoid organs. Despite this understanding, the exact roles of LTα and LTβ in the pathogenesis of the murine model of multiple sclerosis, and experimental autoimmune encephalomyelitis (EAE), remain controversial. Here, we employed a panel of gene‐modified mice with cell‐type restricted ablation of LTα (targeting both membrane‐bound and soluble forms of LTs) to unravel the contributions of LTs from various lymphoid cells, namely T cells, type 3 innate lymphoid cells (ILC3) and B cells, in EAE. We found that the effects of LTα deletion were dependent on the cellular source. ILC3‐derived lymphotoxins exerted a protective role in EAE by regulating the accumulation of IFN‐ɣ‐ and GM‐CSF‐producing T H cells in the CNS. In contrast, T‐cell‐derived lymphotoxins promoted IL‐17A‐ and GM‐CSF‐mediated T H responses in the periphery, whereas B‐cell‐derived lymphotoxins were pathogenic only in the autoantibody‐mediated EAE model. Collectively, our findings unveil the multifaceted involvement of lymphotoxins in EAE pathogenesis and challenge the view that lymphotoxins play a solely pathogenic role in neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Mechanisms of Immunity, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Moscow, 119991, Russia.
- Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, Sirius, Krasnodarsky Krai, 354349, Russia.
- Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
- AG Chronic Inflammation, German Rheumatism Research Center, a Leibniz Institute, Berlin, 10117, Germany.
ORCID-Profile: Violetta S Gogoleva, Andrey A Kruglov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Gogoleva, V. S., Drutskaya, M. S., Vorontsov, A. I., Atretkhany, K. N., Belogurov, A. A., Kruglov, A. A., & Nedospasov, S. A. (2024). Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation. European Journal of Immunology. https://doi.org/10.1002/eji.202350977
Vancouver
Gogoleva VS, Drutskaya MS, Vorontsov AI, Atretkhany KN, Belogurov AA, Kruglov AA, et al. Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation. European Journal of Immunology. 2024. doi:10.1002/eji.202350977
BibTeX
@article{Gogoleva2024,
author = {Gogoleva, Violetta S and Drutskaya, Marina S and Vorontsov, Alexander I and Atretkhany, Kamar-Sulu N and Belogurov, Alexey A and Kruglov, Andrey A and Nedospasov, Sergei A},
title = {Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350977}
}
EUVIMED